Dr Daniel Wall
- Lecturer in Microbiology (Bacteriology)
telephone: 01413307123
email: Donal.Wall@glasgow.ac.uk
Bacterial manipulation of Programmed Cell Death (PCD) during infection facilitates the persistence of bacterial pathogens within host immune cells. This we believe contributes to the prolonged inflammation and severe pathology seen in many bacterial infections. By gaining an understanding of the mechanisms of bacterial targeting of these pathways we aim for therapeutic strategies to combat long term infection (Inflammatory Bowel Disease) and also to use the same knowledge to understand diseases where PCD is malfunctioning (cancer).
Grants and Awards listed are those received whilst working with the University of Glasgow.
- Survival and dissemination of enteric pathogens through exploitation and inhibition of programmed cell death pathways in circulating immune cells.
Biotechnology and Biological Sciences Research Council
2013 - 2016
- Deciphering and harnessing the activation of caspase-3 during infection by Salmonella typhimurium
Society for General Microbiology
2010 - 2010
- Controlled induction of apoptotic enzymes by Salmonella typhimurium drives infection and inflammation
Tenovus-Scotland
2010 - 2011
Invited International Presentations
- 2011: Tenovus Scotland - Sir Robert MacLellan Award
- 2011: University of Strathclyde, UK - "Exploitation of apoptosis by Salmonella Typhimurium"
- 2007: Washington D.C., USA - Experimental Biology Annual General Meeting - Identification of the Salmonella typhimurium SipA functional domain required for intestinal inflammation.
- 2005: Long Island, NY, USA - Cold Spring Harbor Laboratory Microbial Pathogenesis & Host Response meeting. Cold Spring Harbor Laboratory - The S. typhimurium effector protein SipA possesses two discrete functional domains for invasion and inflammation
Prizes, Awards and Distinctions
- 2010: Society for General Microbiology - President's Award
Research Fellowship
- 2010 - 2010: University of Massachusetts, USA - Visiting Academic, University of Massachusetts Medical School, Molecular Genetics and Microbiology Department. Funded by the Society for General Microbiology, UK President's Fund.
